Dupilumab in the Treatment of Pediatric Alopecia Areata

Abroad (travel likely)RecruitingPHASE2

Conditions

Alopecia Areata

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

University of California, Irvine, Irvine, California, United States
Contact: Study coordinator (Marcos Hurtado) · marcosh3@hs.uci.edu · 949-824-7103
Contact: Study coordinator (Jamy Paniagua) · jamyp@hs.uci.edu
Contact: Principal Investigator (Natasha Mesinkovska)
University of California San Diego, San Diego, California, United States
Contact: Study coordinator (Luis F Martinez) · LMartinez1@rchsd.org · 619-507-1182
Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, United States
Contact: Study coordinator (Brian Cheng) · brian.cheng1@northwestern.edu · 312-503-5911
Contact: Study coordinator (Amy Paller, MD) · apaller@luriechildrens.org · 312-227-6060
Northwestern University Feinberg School of Medicine, Chicago, Illinois, United States
Contact: Study coordinator (Brian Cheng) · brian.cheng1@northwestern.edu · 312-503-5911
Contact: Study coordinator (Amy Paller, MD) · apaller@nm.org · 312-227-6060
Contact: Principal Investigator (Amy Paller, MD)
Icahn School of Medicine at Mount Sinai, New York, New York, United States
Contact: Study coordinator (Giselle Singer) · giselle.singer@mssm.edu · 212-241-3288
Contact: Principal Investigator (Emma Guttman-Yassky, MD)

Study leads

Emma Guttman-Yassky, MD, PhD
Principal Investigator
Icahn School of Medicine at Mount Sinai

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Evaluation of Microbiota Transplant Therapy in Patients With Alopecia Areata

Alopecia Areata · Alopecia Totalis · Alopecia Universalis

Abroad (travel likely)RecruitingPHASE2

Minneapolis, United States

Study to Evaluate the Efficacy and Safety of Deuruxolitinib in Japanese Adults With Severe Alopecia Areata

Alopecia Areata

Abroad (travel likely)RecruitingPHASE3

Asahikawa, Japan · Bunkyō City, Japan

Study to Evaluate the Efficacy and Safety of Deuruxolitinib in Adolescents With Severe Alopecia Areata

Alopecia Areata

Abroad (travel likely)RecruitingPHASE3

Birmingham, United States · Scottsdale, United States

A Study to Evaluate the Safety and Effectiveness of Upadacitinib Tablets in Adult and Adolescent Participants in Japan With Alopecia Areata

Alopecia Areata

Abroad (travel likely)RecruitingPHASE3

Nagoya, Japan · Kurume-shi, Japan